A study analysing the association of Inflammatory Bowel Disease as an adverse event with Secukinumab
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Secukinumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 20 Dec 2021 New trial record
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021